- home
- Advanced Search
Filters
Clear All- COVID-19
- Open Access
- Publications
- Other research products
- National Institutes of Health
- Mechanisms of viral proteases in co...
- US
- English
- COVID-19
- Open Access
- Publications
- Other research products
- National Institutes of Health
- Mechanisms of viral proteases in co...
- US
- English
Loading
description Publicationkeyboard_double_arrow_right Article , Other literature type 2018Embargo end date: 24 Sep 2018 Switzerland EnglishPublisher:Public Library of Science (PLoS) Funded by:NIH | Mechanisms of viral prote..., SNSF | Molecular characterizatio..., NIH | EXPERIMENTAL IMMUNOLOGYNIH| Mechanisms of viral proteases in coronavirus replication and pathogenesis ,SNSF| Molecular characterization of Influenza D virus - host interactions ,NIH| EXPERIMENTAL IMMUNOLOGYDaniela Niemeyer; Kirstin Mösbauer; E. Klein; Andrea Sieberg; Robert C. Mettelman; Anna M. Mielech; Ronald Dijkman; Susan C. Baker; Christian Drosten; Marcel A. Müller;SARS-coronavirus (CoV) is a zoonotic agent derived from rhinolophid bats, in which a plethora of SARS-related, conspecific viral lineages exist. Whereas the variability of virulence among reservoir-borne viruses is unknown, it is generally assumed that the emergence of epidemic viruses from animal reservoirs requires human adaptation. To understand the influence of a viral factor in relation to interspecies spillover, we studied the papain-like protease (PLP) of SARS-CoV. This key enzyme drives the early stages of infection as it cleaves the viral polyprotein, deubiquitinates viral and cellular proteins, and antagonizes the interferon (IFN) response. We identified a bat SARS-CoV PLP, which shared 86% amino acid identity with SARS-CoV PLP, and used reverse genetics to insert it into the SARS-CoV genome. The resulting virus replicated like SARS-CoV in Vero cells but was suppressed in IFN competent MA-104 (3.7-fold), Calu-3 (2.6-fold) and human airway epithelial cells (10.3-fold). Using ectopically-expressed PLP variants as well as full SARS-CoV infectious clones chimerized for PLP, we found that a protease-independent, anti-IFN function exists in SARS-CoV, but not in a SARS-related, bat-borne virus. This PLP-mediated anti-IFN difference was seen in primate, human as well as bat cells, thus independent of the host context. The results of this study revealed that coronavirus PLP confers a variable virulence trait among members of the species SARS-CoV, and that a SARS-CoV lineage with virulent PLPs may have pre-existed in the reservoir before onset of the epidemic. Author summary Novel detection and sequencing technologies have greatly improved our knowledge of virus diversity in nature. Metaviromic screening of zoonotic animal reservoirs has become an established approach in pathogen surveillance and pandemic preparedness research. However, knowledge of viral genomes and host-associated viromes is insufficient to predict zoonotic spillover events of reservoir-borne viruses. Phenotypic characterization of important viral functions will be necessary to identify virulence traits that determine the potential of viral emergence. As proof-of-principle, the present study demonstrates relevant functional differences between one of the main host immune antagonists of bat-borne viruses that belong to the same virus species as the epidemic agent of SARS. The antagonist, the papain-like protease, shows double action against IFN-mediated antiviral effects in epidemic SARS-coronavirus (binding and processing of ubiquitin), whereas the homologous protein in bat-borne viruses has only the processing function. This finding is surprising as the papain-like protease is a highly conserved protein domain that was not expected to vary among conspecific coronaviruses. PLP function may represent a variable virulence trait among reservoir-borne viruses. The preformed virulence of the primordial genetic lineage may have supported the emergence of SARS-CoV as a human epidemic agent.
Europe PubMed Centra... arrow_drop_down Europe PubMed CentralArticle . 2018Full-Text: http://europepmc.org/articles/PMC6171950Data sources: PubMed CentralBern Open Repository and Information System (BORIS)Article . 2018 . Peer-reviewedData sources: Bern Open Repository and Information System (BORIS)Bern Open Repository and Information System (BORIS)Article . 2018 . Peer-reviewedData sources: Bern Open Repository and Information System (BORIS)add ClaimPlease grant OpenAIRE to access and update your ORCID works.This Research product is the result of merged Research products in OpenAIRE.
You have already added works in your ORCID record related to the merged Research product.This Research product is the result of merged Research products in OpenAIRE.
You have already added works in your ORCID record related to the merged Research product.All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=10.7892/boris.127515&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.euAccess RoutesGreen gold 63 citations 63 popularity Top 1% influence Top 10% impulse Top 1% Powered by BIP!more_vert Europe PubMed Centra... arrow_drop_down Europe PubMed CentralArticle . 2018Full-Text: http://europepmc.org/articles/PMC6171950Data sources: PubMed CentralBern Open Repository and Information System (BORIS)Article . 2018 . Peer-reviewedData sources: Bern Open Repository and Information System (BORIS)Bern Open Repository and Information System (BORIS)Article . 2018 . Peer-reviewedData sources: Bern Open Repository and Information System (BORIS)add ClaimPlease grant OpenAIRE to access and update your ORCID works.This Research product is the result of merged Research products in OpenAIRE.
You have already added works in your ORCID record related to the merged Research product.This Research product is the result of merged Research products in OpenAIRE.
You have already added works in your ORCID record related to the merged Research product.All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=10.7892/boris.127515&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eu
Loading
description Publicationkeyboard_double_arrow_right Article , Other literature type 2018Embargo end date: 24 Sep 2018 Switzerland EnglishPublisher:Public Library of Science (PLoS) Funded by:NIH | Mechanisms of viral prote..., SNSF | Molecular characterizatio..., NIH | EXPERIMENTAL IMMUNOLOGYNIH| Mechanisms of viral proteases in coronavirus replication and pathogenesis ,SNSF| Molecular characterization of Influenza D virus - host interactions ,NIH| EXPERIMENTAL IMMUNOLOGYDaniela Niemeyer; Kirstin Mösbauer; E. Klein; Andrea Sieberg; Robert C. Mettelman; Anna M. Mielech; Ronald Dijkman; Susan C. Baker; Christian Drosten; Marcel A. Müller;SARS-coronavirus (CoV) is a zoonotic agent derived from rhinolophid bats, in which a plethora of SARS-related, conspecific viral lineages exist. Whereas the variability of virulence among reservoir-borne viruses is unknown, it is generally assumed that the emergence of epidemic viruses from animal reservoirs requires human adaptation. To understand the influence of a viral factor in relation to interspecies spillover, we studied the papain-like protease (PLP) of SARS-CoV. This key enzyme drives the early stages of infection as it cleaves the viral polyprotein, deubiquitinates viral and cellular proteins, and antagonizes the interferon (IFN) response. We identified a bat SARS-CoV PLP, which shared 86% amino acid identity with SARS-CoV PLP, and used reverse genetics to insert it into the SARS-CoV genome. The resulting virus replicated like SARS-CoV in Vero cells but was suppressed in IFN competent MA-104 (3.7-fold), Calu-3 (2.6-fold) and human airway epithelial cells (10.3-fold). Using ectopically-expressed PLP variants as well as full SARS-CoV infectious clones chimerized for PLP, we found that a protease-independent, anti-IFN function exists in SARS-CoV, but not in a SARS-related, bat-borne virus. This PLP-mediated anti-IFN difference was seen in primate, human as well as bat cells, thus independent of the host context. The results of this study revealed that coronavirus PLP confers a variable virulence trait among members of the species SARS-CoV, and that a SARS-CoV lineage with virulent PLPs may have pre-existed in the reservoir before onset of the epidemic. Author summary Novel detection and sequencing technologies have greatly improved our knowledge of virus diversity in nature. Metaviromic screening of zoonotic animal reservoirs has become an established approach in pathogen surveillance and pandemic preparedness research. However, knowledge of viral genomes and host-associated viromes is insufficient to predict zoonotic spillover events of reservoir-borne viruses. Phenotypic characterization of important viral functions will be necessary to identify virulence traits that determine the potential of viral emergence. As proof-of-principle, the present study demonstrates relevant functional differences between one of the main host immune antagonists of bat-borne viruses that belong to the same virus species as the epidemic agent of SARS. The antagonist, the papain-like protease, shows double action against IFN-mediated antiviral effects in epidemic SARS-coronavirus (binding and processing of ubiquitin), whereas the homologous protein in bat-borne viruses has only the processing function. This finding is surprising as the papain-like protease is a highly conserved protein domain that was not expected to vary among conspecific coronaviruses. PLP function may represent a variable virulence trait among reservoir-borne viruses. The preformed virulence of the primordial genetic lineage may have supported the emergence of SARS-CoV as a human epidemic agent.
Europe PubMed Centra... arrow_drop_down Europe PubMed CentralArticle . 2018Full-Text: http://europepmc.org/articles/PMC6171950Data sources: PubMed CentralBern Open Repository and Information System (BORIS)Article . 2018 . Peer-reviewedData sources: Bern Open Repository and Information System (BORIS)Bern Open Repository and Information System (BORIS)Article . 2018 . Peer-reviewedData sources: Bern Open Repository and Information System (BORIS)add ClaimPlease grant OpenAIRE to access and update your ORCID works.This Research product is the result of merged Research products in OpenAIRE.
You have already added works in your ORCID record related to the merged Research product.This Research product is the result of merged Research products in OpenAIRE.
You have already added works in your ORCID record related to the merged Research product.All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=10.7892/boris.127515&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.euAccess RoutesGreen gold 63 citations 63 popularity Top 1% influence Top 10% impulse Top 1% Powered by BIP!more_vert Europe PubMed Centra... arrow_drop_down Europe PubMed CentralArticle . 2018Full-Text: http://europepmc.org/articles/PMC6171950Data sources: PubMed CentralBern Open Repository and Information System (BORIS)Article . 2018 . Peer-reviewedData sources: Bern Open Repository and Information System (BORIS)Bern Open Repository and Information System (BORIS)Article . 2018 . Peer-reviewedData sources: Bern Open Repository and Information System (BORIS)add ClaimPlease grant OpenAIRE to access and update your ORCID works.This Research product is the result of merged Research products in OpenAIRE.
You have already added works in your ORCID record related to the merged Research product.This Research product is the result of merged Research products in OpenAIRE.
You have already added works in your ORCID record related to the merged Research product.All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=10.7892/boris.127515&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eu